Undersøkelse av hukommelse og fysisk aktivitet etter kreftbehandling hos overlevende fra kreft i ungdom og unge voksne (IMPACT)
This study evaluates relationships among physical activity, thinking, and memory after cancer treatment in survivors of adolescent and young adult cancers.
Studieoversikt
Status
Intervensjon / Behandling
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Clinical Trials Referral Office
- Telefonnummer: 855-776-0015
- E-post: mayocliniccancerstudies@mayo.edu
Studer Kontakt Backup
- Navn: Melissa Cole
- Telefonnummer: 480-574-4052
- E-post: mailto:ARZENL@mayo.edu
Studiesteder
-
-
Arizona
-
Scottsdale, Arizona, Forente stater, 85259
- Rekruttering
- Mayo Clinic in Arizona
-
Ta kontakt med:
- Clinical Trials Referral Office
- Telefonnummer: 855-776-0015
- E-post: mayocliniccancerstudies@mayo.edu
-
Ta kontakt med:
- Melissa Cole
- Telefonnummer: 480-574-4052
- E-post: mailto:ARZENL@mayo.edu
-
Hovedetterforsker:
- Diane K. Ehlers, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Patients with primary diagnosis of cancer when 15-39 years old.
Beskrivelse
Inclusion Criteria:
- Adults (aged 18+ years)
- Primary diagnosis of cancer when 15-39 years-old
- Access to a desktop computer or laptop with reliable internet access
- No gross motor impairments that prohibit ambulation
- Willing to complete study requirements
- English speaking
Exclusion Criteria:
- Diagnosed with nonmelanoma skin cancer only
- Not diagnosed with cancer in adolescent and young adult (AYA) age range of 15-39 years
- Scheduled travel during the study period that is not indicative of individual's normal schedule
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: CASE_ONLY
- Tidsperspektiver: CROSS_SECTIONAL
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Observational
Patients complete questionnaires and cognitive tasks and wear an activity monitor to measure physical activity on study. Some patients may optionally participate in an interview on study. |
Non-Interventional Study |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cognitive performance on Stroop task
Tidsramme: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
Up to 4 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Cognitive performance on Visual Memory Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Verbal Memory Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Symbol Digit Coding Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Shifting Attention Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Continuous Performance Test
Tidsramme: Up to 4 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). |
Up to 4 weeks
|
|
Cognitive performance on Reasoning Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Cognitive performance on Four Part Continuous Performance Test
Tidsramme: 2 weeks
|
Assessed using the CNS Vital Signs computerized testing platform ("brain games"). CNS Vital Signs is a computerized neuropsychological/neurocognitive assessment platform used by clinicians and researchers to objectively evaluate brain function and neurocognitive status, offering a range of tests and tools for assessment and management of various neurological and behavioral conditions. |
2 weeks
|
|
Self-reported cognition - FACT-COG
Tidsramme: 2 weeks
|
Evaluated using the Functional Assessment of Cancer Therapy-Cognitive Function (FACT-COG), a 37-item questionnaire assessing cognitive impairment, cognitive abilities, and quality of life over the past 7 days. Responses are on a 5-point scale (Never; About once a week; Two to three times a week; Nearly every day; Several times a day). Higher scores generally indicate better self-reported cognition. |
2 weeks
|
|
Average weekly minutes of physical activity
Tidsramme: 2 weeks
|
Moderate-to-vigorous physical activity (MVPA) will be measured using an accelerometer (activPAL) which participants will wear on their non-dominant thigh for 7 consecutive days. |
2 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Diane K. Ehlers, PhD, Mayo Clinic
Publikasjoner og nyttige lenker
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 24-008654
- 24-008654 (Annen identifikator: Mayo Clinic Institutional Review Board)
- NCI-2025-01193 (Registeridentifikator: CTRP (Clinical Trial Reporting Program))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
De-identified, limited datasets will be shared with other researchers upon request or according to journal publication requirements
IPD-delingstidsramme
At time of first publication (as required by journals) until last manuscript is published.
Tilgangskriterier for IPD-deling
If required by journal and case by case upon request to the PI
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .